FDA examines produce items in US cyclosporiasis outbreak as cases rise - Reuters
FDA examines produce items in US cyclosporiasis outbreak as cases rise Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxNRWNKLThfYUZXMTIwWFBiekVMOVByVHZlb1RmZVBiX0RrYjBkN1ZNRGw1YU4yWFllN1lDWEdsR2I4cmNrWUlKSXkxSHQxR25UVjhKSDVGTE04WmxZTk1uRzJxYUxNQlQ0amFaZjRTVkNucFRmUl93bGhCRzFTV0FmTjdJSzlDVTUyU1piT2RPM0hjenNCbjNiZzhvY3BheU1GTjdIV2VPQVBLUUJXbmF4RDFSeFpLTDh5TGNlVl9zR3IwVHc1VW1aLW81c01wQ3QyRjZvdDR3dVZnNTFzUzQ0?oc=5" target="_blank">FDA examines produce items in US cyclosporiasis outbreak as cases rise</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US measles cases rise to 4,080, CDC says - Reuters
US measles cases rise to 4,080, CDC says Reuters
October 9, 2026 at 05:45 PMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMCDC sees low plague risk, monitors Siberia arrivals after worker death, director says - Reuters
CDC sees low plague risk, monitors Siberia arrivals after worker death, director says Reuters
October 7, 2026 at 08:34 PMRussia says reports of second case linked to Siberian plague lab are false - Reuters
Russia says reports of second case linked to Siberian plague lab are false Reuters
October 8, 2026 at 11:14 AM